Can AI improve the current state of molecular simulation? (Corin & Ari Wagen, Ep #1)
owlposting.com · 10,458 words · saved by 1 readers
2.1 hours listening time
Introduction Jargon explanation Timestamps Transcript In my first (real) podcast episode, I talk with Corin and Ari Wagen, two brothers who I met through my writing. They are building something super cool: a molecular simulation company called Rowan (which recently got into the Nat Friedman AI grant program). We discuss neural network potentials (NNP’s), whether dynamics are useful at all, the role of computational chemistry in drug design, what the future of the field looks like for molecular simulation, and a lot more. Also, for almost every paper/result discussed here, I attach the…
related reading
- A Conversation With Navvye Anand (Bindwell) | Rowanrowansci.com
- Fluid dynamics feels natural once you start with quantum mechanicsyoutube.com
- Andrej Karpathy — AGI is still a decade awaydwarkesh.com
- Generative ML in chemistry is bottlenecked by synthesisowlposting.com
- The ML drug discovery startup trying really, really hard to not cheat (Leash Bio)owlposting.com
- Quantum Chemistry in Drug Discovery | Rowanrowansci.com
- diffuse.onediffuse.one
- A primer on molecular dynamicsowlposting.com
- A primer on molecular dynamicsowlposting.com
- AI After Drug Developmentasteriskmag.substack.com
- Modeling Symmetries | Mark Neumannmarkneumann.xyz
- AquaGen_RXRX.pdfvalencelabs.com